The Surrey CRC is an MHRA Phase I accredited unit (supplementary accreditation) with a wealth of experience in undertaking Phase I and IIa clinical trials. We are the European partner of choice with many Sponsors in undertaking early phase studies.

Safety and quality are at the forefront of our work. Working with our leading experts we ensure the timely delivery of accurate solutions to help our clients achieve faster and better informed decision-making. This also provides the assurance that our volunteers and patients have a rewarding experience during their time with us.

We employ several full-time pharmaceutical physicians and have a substantial clinical team of RGN nurses who oversee the conduct of all our studies.

In terms of Phase I studies we specialise in:

  • Sleep and psychopharmacology studies
  • Oncology studies in patients
  • Vaccine trials including HIV
  • Human performance studies
  • Drug and alcohol interaction studies
  • Age and gender studies

Regulatory activity and report writing

We can work with our clients to manage the complete clinical trials process from start to finish, including protocol development and review, oversight of the regulatory applications, preparation and submission of ethics committee applications, planning and scheduling of the studies and monitoring through to clinical completion and study close-out.

For further information please contact: crc-businessdevelopment@surrey.ac.uk

Further reading